Anticancer Immunotherapy to Circumvent Tumor Resistance to Immune Checkpoint Inhibitors – Cancer Therapy Advisor
Cancer Therapy AdvisorAnticancer Immunotherapy to Circumvent Tumor Resistance to Immune Checkpoint InhibitorsCancer Therapy AdvisorSo they invented a new investigational class of immunotherapies — “bifunctional antibody-ligand traps” (Y-traps) — to do … Continue reading
